X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (104) 104
gastroenterology & hepatology (71) 71
male (68) 68
female (66) 66
middle aged (63) 63
adult (56) 56
aged (48) 48
gastroenterology and hepatology (30) 30
neuroendocrine tumors (29) 29
prognosis (27) 27
life sciences (23) 23
management (23) 23
diagnosis (22) 22
surgery (21) 21
adolescent (20) 20
cancer (20) 20
aged, 80 and over (18) 18
endocrinology & metabolism (18) 18
risk factors (18) 18
treatment outcome (18) 18
liver metastases (16) 16
pancreatic neoplasms - pathology (16) 16
prospective studies (16) 16
retrospective studies (16) 16
tumors (16) 16
france (15) 15
neuroendocrine tumors - pathology (14) 14
survival (14) 14
young adult (14) 14
metastasis (13) 13
follow-up studies (12) 12
chemotherapy (11) 11
crohn's disease (11) 11
endocrine tumors (11) 11
endoscopy (11) 11
oncology (11) 11
pancreas (11) 11
prognostic-factors (11) 11
human health and pathology (10) 10
ulcerative colitis (10) 10
zollinger-ellison-syndrome (10) 10
care and treatment (9) 9
enets consensus guidelines (9) 9
gastrinoma (9) 9
hépatology and gastroenterology (9) 9
magnetic resonance imaging (9) 9
neoplasms (9) 9
neuroendocrine tumors - drug therapy (9) 9
octreotide (9) 9
pancreatic neoplasms - diagnosis (9) 9
pancreatic neoplasms - drug therapy (9) 9
patients (9) 9
somatostatin receptor scintigraphy (9) 9
therapy (9) 9
zollinger-ellison syndrome (9) 9
abridged index medicus (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoid (8) 8
carcinoid-tumors (8) 8
disease-free survival (8) 8
inflammatory bowel disease (8) 8
localization (8) 8
metastases (8) 8
neurosciences (8) 8
somatostatin - analogs & derivatives (8) 8
stomach (8) 8
adenocarcinoma - etiology (7) 7
biopsy (7) 7
case-control studies (7) 7
child (7) 7
crohn disease - complications (7) 7
epidemiology (7) 7
france - epidemiology (7) 7
internal medicine (7) 7
lesions (7) 7
liver neoplasms - secondary (7) 7
neuroendocrine tumors - mortality (7) 7
neuroendocrine tumors - surgery (7) 7
practice guidelines as topic (7) 7
prevalence (7) 7
rectum (7) 7
treatment (7) 7
[ sdv.can ] life sciences [q-bio]/cancer (6) 6
[sdv.can]life sciences [q-bio]/cancer (6) 6
consensus guidelines (6) 6
diagnosis, differential (6) 6
disease (6) 6
disease progression (6) 6
endosonography (6) 6
gastrointestinal neoplasms - pathology (6) 6
intestine (6) 6
lanreotide (6) 6
neoplasm staging (6) 6
neuroendocrine tumor (6) 6
neuroendocrine tumors - therapy (6) 6
pancreatic neoplasms - epidemiology (6) 6
pancreatic neoplasms - mortality (6) 6
pancreatic neoplasms - surgery (6) 6
pancreatic neoplasms - therapy (6) 6
radiology, nuclear medicine & medical imaging (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 6, p. e0125024
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 3, pp. 224 - 233
Journal Article
Journal Article
Journal Article
Gastroenterologie Clinique et Biologique, ISSN 0399-8320, 2004, Volume 28, Issue 3, pp. 262 - 263
Journal Article
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 06/2020, Volume 51, Issue 11, pp. 1039 - 1046
Summary Background Phase III trials have demonstrated the efficacy and safety of ustekinumab in moderate‐to‐severe ulcerative colitis (UC), but few real‐world... 
PHARMACOLOGY & PHARMACY | INFLAMMATORY-BOWEL-DISEASE | CROHNS-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | VEDOLIZUMAB | MAINTENANCE THERAPY | Inflammatory bowel disease | Tumor necrosis factor | Surgery | Rectum | Clinical trials | Remission | Safety | Patients | Bleeding | Ulcerative colitis | Life Sciences | Food and Nutrition | Pharmacology | Pharmaceutical sciences
Journal Article
Digestive and Liver Disease, ISSN 1590-8658, 2017, Volume 49, Issue 4, pp. 359 - 367
Journal Article